http://stevensclark.typepad.com/bioscience_biz/ News, commentary and analysis of the life sciences and the biotechnology business en-US 2009-08-30T13:56:17-05:00 typepad/IgBKhttp://feedburner.google.com http://stevensclark.typepad.com/bioscience_biz/2009/08/fda-puts-brakes-on-geron-stem-cell-trialagain.html The FDA put another clinical hold on Geron's embryonic stem cell trial to treat spinal cord injuries. Before enrolling the first patient, the FDA stopped the trial over concerns about benign growths in animal subjects. Biotechnology News Stem Cells Steven S. Clark, PhD 2009-08-30T13:56:17-05:00 http://stevensclark.typepad.com/bioscience_biz/2009/08/researchers-uncover-possible-link-between-avian-flu-and-parkinsons-disease.html Infection with avian flu might predispose one to Parkinson's disease, according to recently published research. BioScience News Steven S. Clark, PhD 2009-08-12T17:07:40-05:00 http://stevensclark.typepad.com/bioscience_biz/2009/08/study-suggests-h1n1-virus-more-dangerous-than-suspected-.html A new study suggests that the H1N1, or swine flu, is more virulent than thought. Unlike seasonal flu, H1N1 replicates deep in the lungs, a trait associated with flu strains that cause pandemics. BioScience News Steven S. Clark, PhD 2009-08-10T05:13:00-05:00 http://stevensclark.typepad.com/bioscience_biz/2009/08/vc-funding-is-up-for-2q-2009.html World-wide VC investments were substantially up in the 2Q of 2009 compared to 2Q08. Read who the winners were. Investing News Steven S. Clark, PhD 2009-08-07T04:23:00-05:00 http://stevensclark.typepad.com/bioscience_biz/2009/08/whats-new-in-stem-cell-research-and-therapy.html Read what is new in stem cell research and therapy. BioScience Biotechnology Ethics News Stem Cells Steven S. Clark, PhD 2009-08-05T08:37:14-05:00 http://stevensclark.typepad.com/bioscience_biz/2009/08/is-there-an-advantage-to-angel-vs-vc-backing-during-an-ipo.html A recent paper examines the effects of Angel vs VC backing on a company's IPO. Commentary Entrepreneurs/Inventors Investing Steven S. Clark, PhD 2009-08-05T07:43:00-05:00 http://stevensclark.typepad.com/bioscience_biz/2009/08/making-the-transition-from-academia-into-the-world-of-bioentrepreneurship.html A personal perspective on the many challenges faced by scientists when becoming bioentrepreneurs. These can be overcome with a little curiosity, creativity, and commitment. Biotechnology Commentary Entrepreneurs/Inventors Steven S. Clark, PhD 2009-08-03T06:13:00-05:00 http://stevensclark.typepad.com/bioscience_biz/2009/08/is-alzheimers-caused-by-a-presynaptic-deficit-in-calcium-mobilization.html Presynaptic knockout of the presenilin 1 and 2 genes affects neuron function, possibly by interfering with calcium mobilization. Read more to lean how this might be relevant in the pathogenesis of Alzheimer's and other neurodegenerative diseases. BioScience News Steven S. Clark, PhD 2009-08-01T11:07:51-05:00 http://stevensclark.typepad.com/bioscience_biz/2009/07/sbir-reauthorizationd%C3%A9j%C3%A0-vu-all-over-again.html It looks like we are going to get another continuing resolution while the House tries an end-run around Nydia Vazquez’s (D-NY) stonewalling. Biotechnology By Steven S. Clark News Politics Steven S. Clark, PhD 2009-07-28T08:40:30-05:00 http://stevensclark.typepad.com/bioscience_biz/2009/07/the-sbir-clock-is-ticking.html Again the House and Senate are wrangling over disparate SBIR reauthorization bills that are very similar to previous ones that failed to pass the conference committee. With the reauthorization deadline looming at the end of July, Rep Edward Markey is leading an end run about obstructionist Rep Nydia Velazquez and her decidedly anti-small business attitude. Biotechnology By Steven S. Clark Commentary News Politics Steven S. Clark, PhD 2009-07-22T10:03:14-05:00 http://creativecommons.org/images/public/somerights20.gifhttp://creativecommons.org/licenses/by-nd/2.0/